Candel Therapeutics Inc (NASDAQ:CADL), a clinical-stage biopharmaceutical company developing multimodal viral immunotherapies for cancer, announced that CEO Dr Paul Peter Tak will present at the Jefferies Global Healthcare Conference in London on November 18.
The 25-minute presentation will be webcast, with a replay available for 90 days on Candel’s investor website.